Type 1 neovascularization may confer resistance to geographic atrophy amongst eyes treated for neovascular age-related macular degeneration

BACKGROUND: To report a series of age-related macular degeneration (AMD) patients in whom progression to geographic atrophy (GA) in one eye receiving frequent intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) therapy for type 1 neovascularization (NV) was slower than tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhrami-Gavazi, Elona, Balaratnasingam, Chandrakumar, Lee, Winston, Freund, K. Bailey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088476/
https://www.ncbi.nlm.nih.gov/pubmed/27847608
http://dx.doi.org/10.1186/s40942-015-0015-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088476/
https://www.ncbi.nlm.nih.gov/pubmed/27847608
http://dx.doi.org/10.1186/s40942-015-0015-6

Ejemplares similares